Pfizer CentreOne was formed by the 2015 union of Pfizer
CentreSource, a global leader in specialty APIs, and Hospira
One 2 One, one of the world’s premier sterile-injectables CMOs.
We are a multi-specialty CMO embedded within Pfizer, with a
dedicated team of experts devoted to you and your compound.
Although Pfizer CentreOne is a new name, we’re not new to
the industry, with more than 40 years of contract manufacturing
Pfizer CentreOne is a global contract manufacturer that
focuses on API synthesis, sterile injectables fill-finish
and high-potency solids. We guide your drug safely from
development through commercialization, backed by the quality
and resources of Pfizer.
• We reserve capacity, people and resources for your compound.
We have multiple manufacturing facilities in the United States,
Europe and Asia Pacific that have been carefully selected to meet
• Pfizer CentreOne has practical regulatory experience in
more than 100 countries around the world.
API: custom small-molecule API synthesis; and small-
molecule steroid and hormone intermediates and APIs
• For the lifetime of your compound, we provide you with
dedicated technical, regulatory and customer service, so you’re
never alone if an issue arises.
Sterile injectables fill-finish
• Known for our expertise with complex biologics, controlled
substances and lyophilization, 70% of the injectable drugs we
develop and manufacture are for emerging biopharma.
• Our high-potency tablet and capsule manufacturing capabilities
include dedicated resources and appropriate segregation
systems to meet your clinical and commercial needs.
Pfizer CentreOne TM
235 E. 42nd Street
New York, NY 10017 USA
API (U.S.): 1-269-833-4436
API (international): +32-2-714-6502
Sterile injectables: 1-224-212-2267
High-potency solids: 1-269-833-2358